DOI: http://dx.doi.org/10.18203/2349-3933.ijam20200650

The role of pharmacist in handling drug-related problems in breast cancer patients at Dr. Cipto Mangunkusumo Hospital

Yetty Wulandari, Shirly Kumala, Sesilia A. Keban, Erwin Danil Julian

Abstract


Background: DRP (Drug-Related Problems) affects the outcome of chemotherapy treatment to cancer patients. Matters related to DRP can be prevented by a pharmacist by providing drug information to doctors or other health professionals. The objective of this study was to determine the description of DRP, type of DRP, recommendations given by pharmacists on DRPs, acceptance of the results of recommendations and analysis of factors that affect DRPs.

Methods: The research method was carried out through a cross sectional study in which observational data collection was conducted concurrently. The study population was all breast cancer patients from the Division of Surgical Oncology in the period January - April 2018 as many as 228 people. The collected data consisted of dosage suitability, suitability of carrier fluid volume, patient adherence to the schedule for breast cancer patients, recommendations given by pharmacists and the results of acceptance of pharmacist recommendations.

Results: Based on research findings, the incidence of DRP was 76.3%. Most problems were regarding carrier fluid volume (64.5%) and dose mismatch (30%). There was also a DRP combination of carrier fluid volume and dose of 19%. The pharmacist’s recommendation was to change the dose by 15.52%, change the carrier fluid volume by 60.92%, and change the dose and volume of the carrier fluid by 23.56%. The recommended dosage received by doctors was 13 patients (7.47%), changing the volume of carrier fluid received by doctors by 106 patients (60.92%).

Conclusions: Pharmacists can prevent DRPs through providing drug information to doctors or other health professionals so that increased communication between health professionals is required.


Keywords


Breast cancer, Carrier fluid volume, Dose, Drug-related Problems

Full Text:

PDF

References


Krähenbühl-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krähenbühl S. Drug-related problems in hospitals. Drug Safety. 2007 May 1;30(5):379-407.

Viktil KK, Blix HS, Moger TA, Reikvam A. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug‐related problems. Br J Clini Pharmacol. 2007 Feb;63(2):187-95.

Aryzki S, Hereyanti D. Gambaran Pemberian Informasi Obat Pasien Hipertensi di Puskesmas Kuin Raya Banjarmasin. J Insan Farmasi Indon. 2018 Jun 1;1(1):42-50.

Mil JWF van, Horvat N, Westerlund T. Classification for Drug related problems © 2003-2017. The PCNE Classif . 2017;8.01:1-10.

Kemenkes RI. Peraturan Menteri Kesehatan Republik Indonesia No 72 Th. 2016 tentang Standar Pelayanan Kefarmasian di Rumah Sakit. 2016;4.

International JC. Joint Commission International standards for Hospitals. 2013; 71(2).

World Health Organization (WHO). Cancer prevention and control in the context of an integrated approach. 2016:1-9.

Kusuma En. Analisis Drug Related Problems pada Pasien Kanker Padat Stadium Lanjut yang Menjalani Terapi Paliatif di Rumah Sakit Kanker Dharmais. Indonesian Journal of Cancer. 2015;9(2):49-58.

Megawati. Gambaran Ketahanan Hidup Lima Tahun Pasien Kanker Payudara Berdasarkan Karakteristik Demografi dan Faktor Klinis di Rumah Sakit Cipto Mangunkusumo Tahun 2007-2010. (Thesis, Universitas Indonesia). 2012.

Wantini NA. Penyuluhan Deteksi Dini Kanker Payudara Dengan Periksa Payudara Sendiri (Sadari) Di Dusun Candirejo, Tegaltirto, Berbah, Sleman. Inprosiding Semi Nat Internat. 2016;1(1):427-31.

Amandito R, Viryawan CY, Santoso FA, Gautami WA, Panigoro SS. The Characteristics of Breast Cancer Patients in ‘Dharmais’ Hospital National Cancer Center Jakarta Based on Occupational and Environmental Status. Indones J Cancer. 2013 Apr;7(2):53-9.

Fadilah IN. Evaluasi Drug Related Problems (DRPS) Kategori Obat Salah, Dosis Rendah, Dosis Tinggi Dan Interaksi Obat Pada Pasien Kanker Payudara Di Instalasi Rawat Inap RSUD Dr. Moewardi Tahun 2010 (Doctoral dissertation, Universitas Muhammadiyah Surakrta).

Sutrisno E, Purnama P, Muthmainah S. Evaluasi Kepatuhan Pasien Kanker Paudara Dalam Mengikuti Siklus Pengobatan Terapi Disalah Satu Rumah Sakit Pemerintah Bandung , Indonesia. Pros Rakernas dan Pertem Ilm Tah Ikat Apot Indones. 2016;79-82.

Information P, GlaxoSmithKline. Navelbine Injection. 2002:1-26.